Arvinas (ARVN) Research & Development (2017 - 2026)

Arvinas (ARVN) recorded quarterly Research & Development of $60.3 million in Q1 2026, down 1.31% quarter-over-quarter from $61.1 million in Q4 2025, and down 33.59% on a YoY basis from $90.8 million in Q1 2025.

Arvinas (ARVN) Research & Development (2017 - 2026) Analysis & Trends

Arvinas' Research & Development history runs 10 years deep, the most recent figure standing at $60.3 million for Q1 2026.

  • In Q1 2026, Research & Development fell 33.59% year-over-year to $60.3 million; the TTM figure through Mar 2026 stood at $254.7 million (down 28.19% YoY), while the FY2025 annual figure was $285.2 million, down 18.09% from the prior year.
  • Research & Development was $60.3 million for Q1 2026 at Arvinas, down from $61.1 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $103.4 million in Q2 2023 to a low of $60.3 million in Q1 2026.
  • Historically, Research & Development has averaged $81.7 million across 5 years, with a median of $84.3 million in 2024.
  • The sharpest annual moves came in 2022 and 2026: Research & Development surged 90.89% in 2022, then plunged 33.59% in 2026.
  • A 5-year view of Research & Development shows it stood at $98.3 million in 2022, then fell by 3.15% to $95.2 million in 2023, then decreased by 12.5% to $83.3 million in 2024, then decreased by 26.65% to $61.1 million in 2025, then retreated by 1.31% to $60.3 million in 2026.
  • The last three Research & Development figures came in at $60.3 million (Q1 2026), $61.1 million (Q4 2025), and $64.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 4.32 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 15.66 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 626,092.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -101.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -2.30 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 1.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 357,444.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 961.60 Mn
9 Abivax 91.96 Bn 91.96 Bn - -58.00 Mn
10 Arvinas 492.16 Mn -122.74 Mn - 60.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 60.30 Mn
Dec 31, 2025 61.10 Mn
Sep 30, 2025 64.70 Mn
Jun 30, 2025 68.60 Mn
Mar 31, 2025 90.80 Mn
Dec 31, 2024 83.30 Mn
Sep 30, 2024 86.90 Mn
Jun 30, 2024 93.70 Mn
Mar 31, 2024 84.30 Mn
Dec 31, 2023 95.20 Mn
Sep 30, 2023 85.90 Mn
Jun 30, 2023 103.40 Mn
Mar 31, 2023 95.30 Mn
Dec 31, 2022 98.30 Mn
Sep 30, 2022 77.50 Mn
Jun 30, 2022 75.30 Mn
Mar 31, 2022 64.00 Mn
Dec 31, 2021 61.90 Mn
Sep 30, 2021 40.60 Mn
Jun 30, 2021 43.00 Mn